tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Voyager Therapeutics files $400M mixed securities shelf
PremiumThe FlyVoyager Therapeutics files $400M mixed securities shelf
3M ago
Voyager Therapeutics price target lowered to $11 from $12 at Leerink
Premium
The Fly
Voyager Therapeutics price target lowered to $11 from $12 at Leerink
3M ago
Voyager Therapeutics reports Q3 EPS (47c), consensus (52c)
Premium
The Fly
Voyager Therapeutics reports Q3 EPS (47c), consensus (52c)
3M ago
Voyager Therapeutics: Promising Alzheimer’s Portfolio and Innovative NeuroShuttle Platform Justify Buy Rating
PremiumRatingsVoyager Therapeutics: Promising Alzheimer’s Portfolio and Innovative NeuroShuttle Platform Justify Buy Rating
5M ago
3 ‘Strong Buy’ Biotech Stocks Top Analysts Believe Have Over 300% Upside
Premium
Market News
3 ‘Strong Buy’ Biotech Stocks Top Analysts Believe Have Over 300% Upside
5M ago
Buy Rating for Voyager Therapeutics: Promising NeuroShuttle Platform and Strategic Growth Potential
Premium
Ratings
Buy Rating for Voyager Therapeutics: Promising NeuroShuttle Platform and Strategic Growth Potential
5M ago
Voyager Therapeutics: Strong Financial Position and Promising Pipeline Drive Buy Rating
PremiumRatingsVoyager Therapeutics: Strong Financial Position and Promising Pipeline Drive Buy Rating
6M ago
Voyager Therapeutics price target lowered to $8 from $9 at Wedbush
Premium
The Fly
Voyager Therapeutics price target lowered to $8 from $9 at Wedbush
6M ago
Voyager Therapeutics reports Q2 EPS (57c), consensus (52c)
Premium
The Fly
Voyager Therapeutics reports Q2 EPS (57c), consensus (52c)
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100